To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
We provide an updated overview of standard and advanced neuroimaging techniques used in the evaluation of brain abnormalities in fetuses, newborns, and young infants, emphasizing how imaging can identify patterns and estimate the timing of brain injury, helping to distinguish between static malformations, acquired injuries, and progressive or metabolic conditions. Common developmental abnormalities (e.g., neural tube defects, disorders of brain folding and growth, and structural anomalies like cephaloceles and Dandy–Walker malformation) are discussed. The chapter also covers trauma, stroke, brain hemorrhage, infections before or around birth (cytomegalovirus, toxoplasmosis, and rubella), and bacterial infections like meningitis or abscesses. Inherited and acquired metabolic disorders affecting gray and white matter are also illustrated. Techniques such as functional imaging, brain perfusion studies, and chemical analysis using spectroscopy are included. Practical considerations regarding radiation safety, sedation, and use of infant-friendly equipment are addressed, alongside recent technological advances like artificial intelligence–based image enhancement and low-dose CT.
Congenital brain malformations are abnormalities present at birth that result from developmental disruptions of the central nervous system at various stages of brain development. Recognizing and understanding the precise sequence of normal brain development is foundational for grouping certain types of brain malformations. Broadly, these include disorders of neurulation (disruptions of neural tube closure), disorders of ventral patterning (derangements of prosencephalic formation, cleavage, and midline development), disorders of cell generation and proliferation (imbalances in neuronal and glial cell proliferation and apoptosis), disorders of neuronal migration (issues with neuronal cells relocation from their place of origin to the cortex or deep gray nuclei), and disorders of cortical organization (problems with neuronal differentiation and aggregation to form the cortical cytoarchitecture). This chapter will review the primary types of brain malformations within this framework and highlight the key imaging features used by the pediatric neuroradiologist to assist in making the correct diagnosis.
Recent open-label trials show that psychedelics, such as ayahuasca, hold promise as fast-onset antidepressants in treatment-resistant depression.
Methods
To test the antidepressant effects of ayahuasca, we conducted a parallel-arm, double-blind randomized placebo-controlled trial in 29 patients with treatment-resistant depression. Patients received a single dose of either ayahuasca or placebo. We assessed changes in depression severity with the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating scale at baseline, and at 1 (D1), 2 (D2), and 7 (D7) days after dosing.
Results
We observed significant antidepressant effects of ayahuasca when compared with placebo at all-time points. MADRS scores were significantly lower in the ayahuasca group compared with placebo at D1 and D2 (p = 0.04), and at D7 (p < 0.0001). Between-group effect sizes increased from D1 to D7 (D1: Cohen's d = 0.84; D2: Cohen's d = 0.84; D7: Cohen's d = 1.49). Response rates were high for both groups at D1 and D2, and significantly higher in the ayahuasca group at D7 (64% v. 27%; p = 0.04). Remission rate showed a trend toward significance at D7 (36% v. 7%, p = 0.054).
Conclusions
To our knowledge, this is the first controlled trial to test a psychedelic substance in treatment-resistant depression. Overall, this study brings new evidence supporting the safety and therapeutic value of ayahuasca, dosed within an appropriate setting, to help treat depression. This study is registered at http://clinicaltrials.gov (NCT02914769).
This chapter describes the specific magnetic resonance imaging (MRI) features of pediatric multiple sclerosis (MS). It also discusses proposed MRI criteria for pediatric MS and compares these to the MRI diagnostic criteria well established for adult patients who present with a first demyelinating event. MRI studies in children help to understand early pathogenic events that lead to clinical symptoms and signs of MS. MRI detects white matter pathology that represents clinically silent demyelination in adults. The absence of brain or spine lesions on the initial MRI study seems to be associated with very low risk of progression to MS. Studies in adult MS patients have shown that the initial lesion burden on brain imaging may be an important prognostic factor. The MRI criteria for acute disseminated encephalomyelitis (ADEM) include the presence of poorly defined lesions and a high lesion load, associated with thalamus and basal ganglia involvement.